Trpv4−/− mice were generated using AK7 mouse embryonic stem cells. The Trpv4 gene was targeted by homologous recombination with a construct from the International Knockout (KO) Mice Consortium that bears loxP sites flanking the sixth exon (ID: 79331) (49). After selection of several correctly targeted clones, we injected them into C57BL/6J mice host blastocysts. The embryos were transferred into pseudopregnant CD1 mice. Chimeric male offspring were selected on the basis of the coat color. They were mated with C57BL/6J females to assess the transmission of the targeted allele. Mice harboring the targeted allele were mated with ROSA-Flp females to excise the selection cassette. The resulting mice had the sixth exon of the Trpv4 gene flanked with loxP sites (Trpv4lox). Trpv4lox/lox mice were crossed with a mouse line expressing the Cre recombinase under the Phosphoglycerate kinase 1 (PGK-1) promoter to obtain a constitutive Trpv4 KO mouse line (Trpv4−/−). Loss of expression of TRPV4 in Trpv4−/− mice was assessed by quantitative reverse transcription polymerase chain reaction (qRT-PCR), by Western blotting on kidney or PT extracts, and by immunohistochemistry (Fig. 1, A to C).
To obtain the conditional Trpv4 KO mouse model, mice with the Trpv4lox allele were bred with Trpv4−/− mice heterozygous for the ROSA26-lox-stop-lox-tdTomato reporter gene to obtain the Trpv4lox/− Tomlox genotype. To achieve deletion specifically in PTs, Trpv4lox/− mice were crossed with mice expressing the Cre fusion protein under the control of the regulatory elements of the PEPCK gene (PEPCK-Cre transgene) (43). Heterozygous transgenic mice Trpv4lox/− Tomlox/− PEPCK-Cre+/− and their Trpv4lox/− Tomlox/− PEPCK-Cre−/− littermates were identified by PCR genotyping.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.